These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34413183)

  • 21. Editorial: Immunosuppressive therapy in SLE-a reappraisal.
    Br Med J; 1976 Apr; 1(6014):856-7. PubMed ID: 1260380
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recurrent lupus enteritis improved by Azathioprine].
    Marzouk S; Garbaa S; Cherif Y; Jallouli M; Bahri F; Bahloul Z
    Pan Afr Med J; 2015; 20():215. PubMed ID: 26113946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine.
    Bowen DG; Selby WS
    Dig Dis Sci; 2000 Sep; 45(9):1810-3. PubMed ID: 11052324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):249-51. PubMed ID: 4115641
    [No Abstract]   [Full Text] [Related]  

  • 26. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
    Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
    Dubinsky MC
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.
    Boulton-Jones JR; Pritchard K; Mahmoud AA
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1561-5. PubMed ID: 11121903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immuno-suppressive treatment in 15 patients with autoimmune affections or diseases of immunological pathogenesis].
    Lambert PH; Salmon J
    Acta Clin Belg; 1966; 21(3):171-80. PubMed ID: 4381180
    [No Abstract]   [Full Text] [Related]  

  • 30. [Collagen diseases].
    Katsuta Y; Matsuo H
    Nihon Rinsho; 1970 Jul; 28(7):1880-5. PubMed ID: 5466525
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic Lupus Erythematosus-associated Acute Acalculous Cholecystitis Successfully Treated by a Corticosteroid Combined with Azathioprine.
    Kudo N; Takaoka H; Shimomura T; Suzushima H; Fujiyama S
    Intern Med; 2019 Oct; 58(19):2879-2885. PubMed ID: 31243208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.
    Elfving P; Puolakka K; Kautiainen H; Virta LJ; Pohjolainen T; Kaipiainen-Seppänen O
    Lupus; 2016 May; 25(6):666-70. PubMed ID: 26821964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone.
    Oelzner P; Abendroth K; Hein G; Stein G
    Rheumatol Int; 1996; 16(4):133-9. PubMed ID: 8961376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive treatment in immunopathologic disorders].
    Salmon J; Lambert PH
    J Belge Rhumatol Med Phys; 1967; 22(4):267-75. PubMed ID: 4390266
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA; Lambert PH
    Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorials: Immunosuppressive therapy in lupus erythematosus.
    Rothfield NF
    Ann Intern Med; 1975 Nov; 83(5):727-8. PubMed ID: 1200508
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimizing the therapeutic potential of azathioprine/6-mercaptopurine in the treatment of inflammatory bowel disease.
    Papadakis KA
    J Clin Gastroenterol; 2003; 36(5):379-81. PubMed ID: 12702974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.